Schedule 13G ownership disclosure

EAGLE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 269796108

Event date: 2024-10-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-24-004431
Form type
SC 13G/A
Filer
EAGLE PHARMACEUTICALS, INC.
CIK
CIK 827871
Filed
Oct 31, 2024
Reporting period
Oct 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub